Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early terlipressin combined with norepinephrine in septic shock
ChiCTR2000040350Phase 2Not yet recruiting
- Sponsor
- Jiangsu Province Hospital on Integration of Chinese and Western Medicine
- Start
- Oct 2020
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in septic shock comparing Terlipressin combination with Norepinephrine (2 arms). Primary endpoint: Time to target mean arterial pressure. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
terlipressinnorepinephrine
03
Conditions
septic shock
Beyond the preview
Go deeper on ChiCTR2000040350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040350.